Lean Leaf

Lean Leaf operates as a telehealth-focused wellness clinic serving patients across Oklahoma, Texas, Florida, Arizona, Colorado, and Kansas since 2022. Based in Oklahoma City, the practice concentrates on medically supervised weight loss programs utilizing GLP-1 receptor agonist peptides and hormone optimization protocols. The clinic's telehealth model eliminates geographic barriers for patients seeking prescription weight management solutions without requiring in-person office visits, making evidence-based peptide therapy accessible to residents across six states through HIPAA-compliant virtual consultations.

The clinic's weight loss programs center on two FDA-approved peptide medications: semaglutide and tirzepatide. Semaglutide functions as a glucagon-like peptide-1 (GLP-1) receptor agonist that regulates appetite and glucose metabolism, while tirzepatide operates as a dual GIP/GLP-1 receptor agonist affecting both glucose-dependent insulinotropic polypeptide and GLP-1 pathways. Lean Leaf providers prescribe these medications as part of structured weight management programs that include dosage titration protocols designed to minimize gastrointestinal side effects while optimizing metabolic response. The clinic also offers testosterone replacement therapy for patients with clinically diagnosed hypogonadism, addressing hormonal imbalances that can impair weight loss efforts and metabolic health. Treatment plans incorporate baseline laboratory testing, ongoing monitoring of metabolic markers, and medication adjustments based on individual patient response and tolerance.

Lean Leaf's clinical team conducts initial consultations via secure video platforms, reviewing patient medical history, current medications, weight loss goals, and contraindications for peptide therapy. Providers evaluate candidates for semaglutide or tirzepatide based on BMI criteria, previous weight loss attempts, comorbid conditions such as type 2 diabetes or cardiovascular risk factors, and individual metabolic profiles. The consultation process includes discussion of realistic weight loss expectations, potential side effects including nausea and gastrointestinal discomfort during dose escalation, and the importance of dietary modifications alongside pharmacotherapy. For hormone therapy candidates, the clinic requires comprehensive hormone panels including total and free testosterone, estradiol, and thyroid function tests before initiating treatment protocols.

Patients receive medications through partner pharmacies with direct shipping to their homes, streamlining the prescription fulfillment process for ongoing treatment. The clinic maintains communication channels for patients to report side effects, ask dosing questions, or request protocol adjustments between scheduled follow-up appointments. Lean Leaf's pricing structure for peptide medications and consultation services is discussed transparently during the initial evaluation, with patients receiving clear information about monthly medication costs, consultation fees, and laboratory testing expenses before committing to treatment. Follow-up appointments occur at regular intervals to assess weight loss progress, review adherence to prescribed protocols, and modify dosages as patients advance through titration schedules or reach maintenance phases.

The Oklahoma City-based practice differentiates itself through multi-state telehealth availability, allowing patients in rural areas or underserved markets to access peptide-based weight management without traveling to metropolitan medical centers. Lean Leaf's focus on the two most clinically studied GLP-1 pathway medications—semaglutide and tirzepatide—reflects an evidence-based approach rather than offering unproven peptide combinations. The clinic's 5.0-star rating across 37 Google reviews indicates consistent patient satisfaction with communication responsiveness, treatment outcomes, and the telehealth service model. For Oklahoma residents and patients across the five additional states where Lean Leaf maintains licensure, the clinic provides a remote access point for physician-supervised peptide therapy that combines metabolic medication management with hormonal optimization for comprehensive wellness support.